LOEB PARTNERS CORP - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 62 filers reported holding PARATEK PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
LOEB PARTNERS CORP ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2017$226,000
+73.8%
9,000
-10.0%
0.07%
+50.0%
Q3 2016$130,000
-6.5%
10,0000.0%0.05%0.0%
Q2 2016$139,000
-8.6%
10,0000.0%0.05%
-14.8%
Q1 2016$152,00010,0000.05%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Omega Fund Management, LLC 2,600,410$10,480,0003.34%
Roumell Asset Management, LLC 340,323$1,372,0003.14%
Abingworth LLP 1,041,131$4,185,0002.02%
ICM ASSET MANAGEMENT INC/WA 448,315$1,807,0001.48%
Trellus Management Company, LLC 147,055$593,0000.99%
Prosight Management, LP 450,000$1,814,0000.80%
ARMISTICE CAPITAL, LLC 2,268,000$9,140,0000.53%
Arbiter Partners Capital Management LLC 848,069$3,418,0000.50%
NEXPOINT ASSET MANAGEMENT, L.P. 966,493$3,895,0000.30%
GENERAL AMERICAN INVESTORS CO INC 644,323$2,597,0000.24%
View complete list of PARATEK PHARMACEUTICALS INC shareholders